- Home
- NLSP vs ERC Comparison
NLSP vs ERC Comparison
Compare NLSP & ERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- ERC
- Stock Information
- Founded
- NLSP 2015
- ERC 2003
- Country
- NLSP Switzerland
- ERC United States
- Employees
- NLSP N/A
- ERC N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- ERC Finance/Investors Services
- Sector
- NLSP Health Care
- ERC Finance
- Exchange
- NLSP Nasdaq
- ERC Nasdaq
- Market Cap
- NLSP 243.8M
- ERC N/A
- IPO Year
- NLSP 2021
- ERC N/A
- Fundamental
- Price
- NLSP $4.45
- ERC $9.40
- Analyst Decision
- NLSP
- ERC
- Analyst Count
- NLSP 0
- ERC 0
- Target Price
- NLSP N/A
- ERC N/A
- AVG Volume (30 Days)
- NLSP 32.7K
- ERC 64.4K
- Earning Date
- NLSP 10-18-2024
- ERC 01-01-0001
- Dividend Yield
- NLSP N/A
- ERC 8.37%
- EPS Growth
- NLSP N/A
- ERC N/A
- EPS
- NLSP N/A
- ERC 0.72
- Revenue
- NLSP N/A
- ERC N/A
- Revenue This Year
- NLSP N/A
- ERC N/A
- Revenue Next Year
- NLSP N/A
- ERC N/A
- P/E Ratio
- NLSP N/A
- ERC $12.92
- Revenue Growth
- NLSP N/A
- ERC N/A
- 52 Week Low
- NLSP $4.08
- ERC $8.51
- 52 Week High
- NLSP $35.60
- ERC $9.74
- Technical
- Relative Strength Index (RSI)
- NLSP 36.17
- ERC 47.52
- Support Level
- NLSP $4.72
- ERC $9.31
- Resistance Level
- NLSP $5.36
- ERC $9.47
- Average True Range (ATR)
- NLSP 0.56
- ERC 0.06
- MACD
- NLSP -0.01
- ERC -0.02
- Stochastic Oscillator
- NLSP 19.79
- ERC 33.33
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.